On waiting time for elective surgery admissions Following: Armstrong, 2000 A,B Sobolev, Levy, and Kuramato, 2000 Sobolev and Kuramato, 2008.

Slides:



Advertisements
Similar presentations
Surviving Survival Analysis
Advertisements

ESTIMATION OF THE NET MIGRATION BY COMPARING TWO SUCCESSIVE CENSUSES Michel POULAIN GéDAP UCL Belgium.
Impact of Preoperative Renal Dysfunction in Patients Undergoing Off- pump vs On-pump Coronary Artery Bypass.
6/1/2015survival analysis 1 If you want peace, you must first have peace of mind. To have peace of mind, you must first act according to reason. With reason,
Main Points to be Covered
Measures of disease frequency (I). MEASURES OF DISEASE FREQUENCY Absolute measures of disease frequency: –Incidence –Prevalence –Odds Measures of association:
Analysis of Complex Survey Data
Survival analysis Brian Healy, PhD. Previous classes Regression Regression –Linear regression –Multiple regression –Logistic regression.
Marshall University School of Medicine Department of Biochemistry and Microbiology BMS 617 Lecture 10: Survival Curves Marshall University Genomics Core.
Essentials of survival analysis How to practice evidence based oncology European School of Oncology July 2004 Antwerp, Belgium Dr. Iztok Hozo Professor.
The life table LT statistics: rates, probabilities, life expectancy (waiting time to event) Period life table Cohort life table.
1 Introduction to medical survival analysis John Pearson Biostatistics consultant University of Otago Canterbury 7 October 2008.
Laura Mucci, Pharm.D. Candidate Mercer University 2012 Preceptor: Dr. Rahimi February 2012.
Flow Diagram of the Main HOPE Trial and the HOPE-TOO Trial Extension The HOPE and HOPE-TOO Trial Investigators JAMA. 2005;293:
Multiple Arterial Bypass Grafting Should Be Routine Robert F Tranbaugh, David J Lucido, Kamellia R Dimitrova, Darryl M Hoffman, Charles M Geller, John.
Introduction Sample Size Calculation for Comparing Strategies in Two-Stage Randomizations with Censored Data Zhiguo Li and Susan Murphy Institute for Social.
Is avoidable mortality a good measure of the quality of hospital care? Dr Helen Hogan Clinical Senior Lecturer in Public Health London School of Hygiene.
Lecture 5: The Natural History of Disease: Ways to Express Prognosis
01/20151 EPI 5344: Survival Analysis in Epidemiology Actuarial and Kaplan-Meier methods February 24, 2015 Dr. N. Birkett, School of Epidemiology, Public.
Is avoidable mortality a good measure of the quality of healthcare? Dr Helen Hogan Clinical Senior Lecturer in Public Health London School of Hygiene and.
Mean Cumulative Function (MCF) For Recurrent Events
The ILLUMINATE Study: Enrollment and Outcomes Philip Barter, et al. N Engl J Med 2007;357:
Bangalore S, et al. β-Blocker use and clinical outcomes in stable outpatients with and without coronary artery disease. JAMA. 2012;308(13): ?
Some survival basics Developments from the Kaplan-Meier method October
INTRODUCTION TO CLINICAL RESEARCH Survival Analysis – Getting Started Karen Bandeen-Roche, Ph.D. July 20, 2010.
Performance assessment A performance assessment framework is a collation of statistics across a district or within a hospital and is far removed from.
Date of download: 6/1/2016 Copyright © The American College of Cardiology. All rights reserved. From: Early and long-term clinical outcomes associated.
The JUPITER Trial Reference Ridker PM. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med. 2008;359:2195–2207.
Date of download: 6/24/2016 Copyright © The American College of Cardiology. All rights reserved. From: The Year in Cardiovascular Surgery J Am Coll Cardiol.
Methods and Statistical analysis. A brief presentation. Markos Kashiouris, M.D.
Source: Behavioral Risk Factor Surveillance System, CDC. Obesity Trends* Among U.S. Adults BRFSS, 1990 (*BMI ≥30, or ~ 30 lbs. overweight for 5’ 4” person)
Date of download: 9/19/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Association Between Endoscopic vs Open Vein-Graft.
Adnan K. Chhatriwalla, MD Saint-Luke’s Mid America Heart Institute
Trial profile SAS denotes the Simvastatin in Aortic Stenosis Study
April 18 Intro to survival analysis Le 11.1 – 11.2
Lako S, Daka A, Nurka T, Dedej T, Memishaj S
Results of Coronary Artery Endarterectomy and Coronary Artery Bypass Grafting for Diffuse Coronary Artery Disease  Srikrishna Sirivella, MD, Isaac Gielchinsky,
Coarctation of the Aorta Feasibility of a long-term follow-up study
Successful CTO PCI Associated with Lower Mortality Risk
Repeat Sternotomy: No Longer a Risk Factor in Mitral Valve Surgical Procedures  Mehrdad Ghoreishi, MD, Murtaza Dawood, MD, Gerald Hobbs, PhD, Chetan Pasrija,
Presenter: Wen-Ching Lan Date: 2018/05/09
Early postoperative outcome and medium-term survival in 540 diabetic and 2239 nondiabetic patients undergoing coronary artery bypass grafting  Zoltán.
The challenge of associated intramural hematoma with endovascular repair for penetrating ulcers of the descending thoracic aorta  Himanshu J. Patel, MD,
Mean eGFR among survivors after CABG surgery vs all-cause deaths
LUNG TRANSPLANTATION Pediatric Recipients ISHLT 2010
Aortic valve replacement in patients with mild or moderate aortic stenosis and coronary bypass surgery  Jeremy J. Pereira, MB, Krzysztof Balaban, MD,
Frederick L Grover, MD  The Annals of Thoracic Surgery 
Long-Term Survival of Patients With Ischemic Cardiomyopathy Treated by Coronary Artery Bypass Grafting Versus Medical Therapy  Eric J. Velazquez, MD,
Risk Stratification and Interventional Cardiology: Robert L
Kaplan-Meier curves: revascularisation rate (PCI or CABG) was significantly higher (p
Enrollment and Outcomes
A decade after the Surgical Treatment for Ischemic Heart Failure (STICH) trial: Weaving firm clinical recommendations from lessons learned  Robert E.
Kaplan-Meier estimate of mortality in 1798 propensity score matched pairs with a propensity score >0.5 for the whole observational period. Kaplan-Meier.
Baseline Characteristics of the Study Participants
Repeat Sternotomy: No Longer a Risk Factor in Mitral Valve Surgical Procedures  Mehrdad Ghoreishi, MD, Murtaza Dawood, MD, Gerald Hobbs, PhD, Chetan Pasrija,
Nonelective cardiac surgery in the elderly: Is it justified?
EuroSCORE II and N-terminal pro-B-type natriuretic peptide for risk evaluation: an observational longitudinal study in patients undergoing coronary artery.
A personal experience with factors influencing survival after elective open repair of infrarenal aortic aneurysms  Norman R. Hertzer, MD, Edward J. Mascha,
E.Stanley Crawford, M.D., Ralph W. DeNatale, M.D. 
Glenn N. Levine et al. JACC 2011;58:e44-e122
Age and valve size effect on the long-term durability of the Carpentier-Edwards aortic pericardial bioprosthesis  Michael K Banbury, MD, Delos M Cosgrove,
Trends in Patient Characteristics and Outcomes of Coronary Artery Bypass Grafting in the 2000 to 2012 Medicare Population  Christian McNeely, MD, Stephen.
Kaplan-Meier survival estimates for major cardiovascular events.
Baseline characteristics of study population
Davide Capodanno et al. JCIN 2009;2:
Kaplan-Meier estimate of mortality in the two treatment strategies with significant difference between the two groups (log-rank test
Kaplan-Meier survival curves and the log rank test
Kaplan-Meier estimates for survival in metastatic disease for the whole patient cohort (A) and in patients with or without history of adjuvant trastuzumab.
Cumulative probability of CIN2 stratified by HPV test results.
The Ottawa COPD (chronic obstructive pulmonary disease) Risk Scale (OCRS) is used in the emergency department (ED) to identify patients with acute COPD.
Presentation transcript:

On waiting time for elective surgery admissions Following: Armstrong, 2000 A,B Sobolev, Levy, and Kuramato, 2000 Sobolev and Kuramato, 2008

Introduction Vladimir: What do we do now? Estragon: Wait. Waiting for Godot Samuel Beckett The waiting times for coronary artery bypass grafting (CABG) were such that 25%,50%,75% and 90% of the patients underwent surgery within 5,12,23 and 46 weeks. (Sobolev & Kuramato, 2008)

Part 1 – Introduction Part 2 – Lists of time to admission Part 3 – Waiting time census Part 4 – Waiting time estimation Part 5 – Censored observations Part 6 – Competing risks Outline

Introduction How long do people wait? England, 1994 (Armstrong, 2000)

Introduction 2. Waiting time census. Databases: 1. List of time to admission (Armstrong, 2000)

Part 1 – Introduction Part 2 – Lists of time to admission Part 3 – Waiting time census Part 4 – Waiting time estimation Part 5 – Censored observations Part 6 – Competing risks Outline

Lists of time to admission List of time to admission : (Armstrong, 2000) 554,751

Lists of time to admission Define: A t = Number admitted to surgery in period t The probability for surgery in period t :

Lists of time to admission (Sobolev et al., 2000) “We understand that 14% of patients in Australia may expect to be removed from the waiting list for some reason other than admission.” (Armstrong, 2000)

From the two types of patients: 7 of the one day waiting time compared to 1 of the seven days waiting time were counted. Lists of time to admission

Estimated probability of undergoing surgery as a function of waiting time. Data for a single group of patients awaiting vascular surgery. (Sobolev & Kuramato, 2008)

Part 1 – Introduction Part 2 – Lists of time to admission Part 3 – Waiting time census Part 4 – Waiting time estimation Part 5 – Censored observations Part 6 – Competing risks Outline

Waiting time census Waiting time census: (Armstrong, 2000)

Define: W t = Number that waited period of t at time of census. Waiting time census

From the two types of patients: 1 of the one day waiting time compared to 7 of the seven days waiting time were counted. Waiting time census

Problems: 1. Short waiting periods do not appear in census. 2. Stationary assumption: Patients who enrolled in different periods are compared. “But the hospital waiting list for England would not have attracted so much attention if it were really stationary…” (Armstrong, 2000) Waiting time census

Problems: 3. It is not clear how long a patient waited if the patient appears in one census but not in the next. More specifically, a patient was counted in the Sep. 0-3 category and does not appear in the Dec. 3-6 category. How long did the patient wait? Waiting time census

Part 1 – Introduction Part 2 – Lists of time to admission Part 3 – Waiting time census Part 4 – Waiting time estimation Part 5 – Censored observations Part 6 – Competing risks Outline

Waiting time estimation Define: S t = Number at risk at the end of period t A t = Number admitted to surgery in period t C t = Number censored in period t Waiting time estimation: The probability for surgery in period t for patients still at risk at time t : Question: How to treat censored observations?

The probability for surgery in period t for patients still at risk at time t : By Bayes’ rule hence Waiting time estimation

We have seen The survival function can be estimated by which is called the Kaplan Meier estimator Waiting time estimation

Part 1 – Introduction Part 2 – Lists of time to admission Part 3 – Waiting time census Part 4 – Waiting time estimation Part 5 – Censored observations Part 6 – Competing risks Outline

Censored observations Censored observations: Note that censored observations are not counted either in the list of time to admission or in the census. Question 1: How many censored observations are there? Question2: How to treat censored observations?

Censored observations Question 1: How many observations in the category of 0-3 months that enrolled between July to Sep. were censored between Oct. and Dec.?

Censored observations Answer: 1. Calculate the difference between the number in category 0-3 in the Sep. census to those still waiting in the Dec. census. Note: The difference accounted also for observations from 3-6 months category.

Censored observations 2. Calculate how many of the patients that were enrolled between July and Sep. where admitted between Oct. and Dec.

Censored observations So far: Number of patients that enrolled between July and Sep. and were censored between Oct. and Dec. is: # enrolled in July-Sep. and not listed in Dec. census minus # enrolled in July-Sep. and admitted Oct.-Dec. Question: How many of the censored observations were patients that waited 0-3 months?

Censored observations 3. Of the patients that enrolled between July and Sep. and were admitted between Oct. and Dec., calculate which percentage waited 0-3 months.

Censored observations Conclude: An estimate of the number of patients that: enrolled between July and Sep., were censored between Oct. and Dec. and waited 0-3 months: Number censored % that waited 0-3 months

Censored observations Censored observations: Question2: How to treat censored observations? Answer: First, note that in the Kaplan-Meier estimator, censored observations from periods t+1,… are indeed included.

Censored observations Question2: How to treat censored observations at period t ? Answer: 1. Assume that all were censored in the beginning of the period and need not be included (Lower Bound) 2. Assume that all were censored at the end of the period and need to be included (Upper bound)

Censored observations (Armstrong, 2000)

Part 1 – Introduction Part 2 – Lists of time to admission Part 3 – Waiting time census Part 4 – Waiting time estimation Part 5 – Censored observations Part 6 – Competing risks Outline

Competing risks Competing risks: “A competing event is any event whose occurrence either precludes the occurrence of another event under examination or fundamentally alters the probability of occurrence of this other event.” (Gooley et al., 1999) Examples: 1. Medical: Death is primary, surgery is competing event. 2. Medical: Surgery is primary, urgent surgery is competing event. 3. Call centers: Abandonment is primary, service is competing event.

Competing risks Cumulative incidence function (CIF) The probability of any event happening is partitioned to the probabilities of each type of event. Define: S t = Number at risk at the end of period t E t = Number of primary events in period t A t = Number of competing events in period t

Competing risks Cumulative incidence function (CIF) S t = Number at risk at the end of period t E t = Number of primary event in period t A t = Number of competing event in period t Note: =>Kaplan-Meier estimator does not work!

Competing risks Cumulative incidence function (CIF) Define the survival function as before (using Kaplan-Meier) Define the CIF as

Competing risks Death while waiting (CABG) CIF of preoperative death during or before a certain week since registration for elective CABG

Competing risks Death while waiting (CABG) CIF compared to Kaplan-Meier

Competing risks Death while waiting (CABG) The Conditional Probability Function (CPF) of preoperative death from CABG.

References 1. Armstrong, P.W., “First steps in analysing NHS waiting times: avoiding the 'stationary and closed population' fallacy.” Statist. Med Armstrong, P.W., “Unrepresentative, invalid and misleading: are waiting times for elective admission wrongly calculated?”, J Epidemiol Biostat Sobolev, B., Levy, A., and Kuramoto, L., “Access to surgery and medical consequences of delays” In: R. Hall ed. Patient Flow: Reducing Delay in Healthcare Delivery, Sobolev, B., Kuramoto, L., Analysis of Waiting-Time Data in Health Services Research. 1st edition. Hardcover, Springer, 2007;